Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute …
… the relationship between pretreatment cytogenetics and … cumulative incidence of relapse
(CIR), and OS. We also analyzed the outcome of patients with 3 or 4 cytogenetic abnormalities…
(CIR), and OS. We also analyzed the outcome of patients with 3 or 4 cytogenetic abnormalities…
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid …
… This study explores the prognostic significance of cytogenetic abnormalities in AML …
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of …
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of …
Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of …
… Cytogenetic abnormalities are identified in approximately 55… most important pretreatment
factors for predicting clinical outcome. … had a successful bone marrow (BM) cytogenetic analysis …
factors for predicting clinical outcome. … had a successful bone marrow (BM) cytogenetic analysis …
Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid …
… outcome in AML, pretreatment cytogenetics is recognized as … immediately following induction
chemotherapy is predictive of a … Cumulative incidence of relapse according to the presence …
chemotherapy is predictive of a … Cumulative incidence of relapse according to the presence …
Southwestern Oncology Group pretreatment risk criteria as predictive or prognostic factors in acute myeloid leukemia
A Espirito Santo, S Chacim… - Molecular and …, 2017 - spandidos-publications.com
… the implications of pretreatment risk criteria as predictive or … (SWOG) coding pretreatment
risk criteria/cytogenetic score. … relevant for complete response to induction therapy, but not …
risk criteria/cytogenetic score. … relevant for complete response to induction therapy, but not …
Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction …
S Balleisen, A Kuendgen, B Hildebrandt, R Haas… - Leukemia research, 2009 - Elsevier
… Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative
incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: …
incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: …
Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia
… Cumulative incidence was used to estimate the endpoints of NRM, RI, … , cytogenetic
abnormalities have been previously established as robust predictors of the risk of primary induction …
abnormalities have been previously established as robust predictors of the risk of primary induction …
Clinical profile, cytogenetics and treatment outcomes of adult acute myeloid leukemia
MSN Udupa, KG Babu, MCS Babu… - Journal of cancer …, 2020 - journals.lww.com
… Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative
incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: …
incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: …
[HTML][HTML] Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal …
C Niederwieser, D Nicolet, AJ Carroll, JE Kolitz… - …, 2016 - ncbi.nlm.nih.gov
… , 12 relapse-free survival, 14 cumulative incidence of relapse, 12 an … were not detected
prior to induction treatment. DFS of these … abnormality at CR, whether related to the pre-treatment …
prior to induction treatment. DFS of these … abnormality at CR, whether related to the pre-treatment …
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study
SS Farag, AS Ruppert, K Mrózek, RJ Mayer… - Journal of clinical …, 2005 - ascopubs.org
… The 5-year cumulative incidence of relapse (CIR) was 62% and 67% for groups I and …
Pretreatment cytogenetic abnormalities are among the most important prognostic factors predicting …
Pretreatment cytogenetic abnormalities are among the most important prognostic factors predicting …